Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775735 · ClinicalTrials.gov registry record · NA
Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01775735 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 28 participants.
The verdict
NCT01775735, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of occipital nerve stimulation (ONS) using the Boston Scientific Corporation (BSC) Precision™ System in the management of intractable chronic migraine, when used in conjunction with anti-migraine medications.
Interventions
- DEVICE Occipital nerve stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04-10 |
| Est. Completion | 2017-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775735
The ClinicalTrials.gov registry entry for NCT01775735 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Occipital nerve stimulator is the first listed.
NCT01775735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01775735 about?
NCT01775735 is a clinical study titled "Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE". The primary objective of this study is to evaluate the safety and efficacy of occipital nerve stimulation (ONS) using the Boston Scientific Corporation (BSC) Precision™ System in the management of intractable chronic migraine, when used in conjunction with anti-migraine medications.
What is the current status of trial NCT01775735?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2013-04-10. Estimated completion is 2017-01-19.
What interventions are being tested in trial NCT01775735?
The interventions under investigation include: Occipital nerve stimulator (DEVICE).
Who is sponsoring clinical trial NCT01775735?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.